NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 36 filers reported holding NRX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $14,490 | -26.7% | 30,000 | 0.0% | 0.00% | – |
| Q1 2023 | $19,770 | -50.3% | 30,000 | -16.2% | 0.00% | – |
| Q4 2022 | $39,748 | – | 35,809 | +10884.4% | 0.00% | – |
| Q3 2022 | $0 | – | 326 | +1.9% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 320 | -78.5% | 0.00% | – |
| Q1 2022 | $3,000 | -85.7% | 1,487 | -66.0% | 0.00% | – |
| Q4 2021 | $21,000 | -93.9% | 4,371 | -88.3% | 0.00% | – |
| Q3 2021 | $347,000 | – | 37,462 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Texas Capital Bank Wealth Management Services Inc | 63,290 | $41,714 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 230,700 | $152,054 | 0.00% |
| Virtu Financial LLC | 46,210 | $30 | 0.00% |
| United Asset Strategies, Inc. | 18,300 | $12,062 | 0.00% |
| HBK Sorce Advisory LLC | 29,230 | $19,266 | 0.00% |
| UBS Group AG | 18,611 | $12,265 | 0.00% |
| NewEdge Advisors, LLC | 2,125 | $1,401 | 0.00% |
| OSAIC HOLDINGS, INC. | 27,225 | $17,933 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 30,000 | $19,770 | 0.00% |
| WELLS FARGO & COMPANY/MN | 5,309 | $3,500 | 0.00% |